Biotechnology - Sci-Tech Bulletin

Seven microbial solutions revolutionizing environmental biotechnology

Seven microbial solutions for sustainable environment

Microbial bioprocesses offer promising solutions to global environmental challenges through innovative strategies such as enhanced carbon dioxide (CO₂) capture, improved soil water retention, plastic biodegradation, removal of pharmaceuticals and endocrine-disrupting chemicals, biological nitrogen fixation, phosphorus recovery and recycling, and efficient conversion of lignocellulosic biomass. These advances demonstrate the practical potential of engineered microorganisms for sustainable development. Technological advancements in microbial biotechnology can support climate action, resource conservation, pollution control, sustainable agriculture, and the transition to a resilient, circular bioeconomy with tangible environmental and societal benefits.

Seven microbial solutions for sustainable environment Read More »

Artificial Intelligence Enhances Breast Cancer Diagnosis Through Deep Learning

Deep learning and convolutional neural networks (CNNs) are transforming breast cancer diagnosis by automating the analysis of histopathological images. Researchers developed a workflow that integrates image preprocessing, hematoxylin–eosin stain separation, K-means clustering, and CNN-based classification to enhance diagnostic accuracy. By filtering poor-quality images and focusing on tumor-rich regions, the model achieved strong classification performance, with 79.0% Top-1 accuracy and 94.5% Top-5 accuracy. Thus, potential use of AI is able to reduce diagnostic variability, support pathologists in clinical decision-making, streamline pathology workflows, and improve access to reliable breast cancer diagnosis, particularly in resource-limited healthcare settings.

Artificial Intelligence Enhances Breast Cancer Diagnosis Through Deep Learning Read More »

Plant-Made Proteins: The Future of Sustainable Biopharmaceutical Production

Plant-made proteins are emerging as a transformative platform for producing vaccines, antibodies, enzymes, and other biopharmaceuticals, offering a sustainable, cost-effective, and scalable alternative to conventional protein production systems. Advances in plant-based expression systems, genetic engineering, process optimization, and downstream manufacturing have significantly improved protein yield, quality, and scalability. Commercial successes such as Elelyso® and the Ebola therapy ZMapp demonstrate the growing maturity of molecular farming. Plant-made proteins have promising applications in rapid pandemic response, oral drug delivery through bioencapsulation, veterinary medicine, and affordable pharmaceutical production for developing countries.

Plant-Made Proteins: The Future of Sustainable Biopharmaceutical Production Read More »

IMOP-Cancer Predicts Tumor Behaviour Through Mutation Order

IMOP-Cancer, a computational framework identifies how the order of genetic mutations influences cancer progression, prognosis, immune response, and treatment outcomes. Using genomic and transcriptomic data from over 9,000 tumours across 33 cancer types; 106,034 mutation order pairs have been identified that significantly affects cancer phenotypes. The framework integrates mutation timing, cancer cell fraction, phylogenetic analysis, and gene expression profiling to reveal biologically meaningful mutation sequences that influences tumour proliferation, immune activity, drug sensitivity, and patient survival, highlighting its potential in advance precision oncology, prognostic prediction, and personalized cancer therapy.

IMOP-Cancer Predicts Tumor Behaviour Through Mutation Order Read More »

Green Nanotechnology using plants for Cancer and Inflammation treatment

Green-synthesized silver nanoparticles (AgNPs) are developed using the medicinal plant Taxus wallichiana, whose phytochemicals served as natural reducing and stabilizing agents. Characterization by UV–Vis spectroscopy, SEM, FTIR, and GC–MS confirmed the formation of stable spherical and oval nanoparticles measuring 10–20 nm. Biological evaluation demonstrated enhanced cytotoxicity against U87 glioblastoma cells (up to 85.45%) and superior anti-inflammatory activity compared with the crude plant extract, while acute toxicity studies showed no adverse effects at doses up to 2000 mg/kg. These findings underscore the potential of Taxus wallichiana-derived AgNPs as sustainable nanotherapeutics for cancer and inflammatory diseases.

Green Nanotechnology using plants for Cancer and Inflammation treatment Read More »

Antimicrobial Resistance and Global Antibiotic Use: Trends and Projections Through 2030

Global antibiotic consumption increased steadily between 2016 and 2023, with only a temporary decline during the COVID-19 pandemic before rebounding, particularly in middle-income countries. An analysis of data from 67 countries found a 16.3% increase in antibiotic consumption over the study period. Looking ahead, the researchers project global antibiotic use to rise by 52.3%, from 49.3 billion defined daily doses (DDDs) in 2023 to 75.1 billion DDDs by 2030, if current trends continue. Stronger antimicrobial stewardship, improved sanitation, expanded vaccination, better diagnostics, and effective regulatory policies are essential to curb unnecessary antibiotic use and slow the spread of antimicrobial resistance.

Antimicrobial Resistance and Global Antibiotic Use: Trends and Projections Through 2030 Read More »

First Human Trial of stem cell-derived islet transplant offers new hope for Type 1 Diabetes

This first-in-human Phase I clinical trial evaluated a personalized stem cell therapy for Type 1 Diabetes. Researchers chemically reprogrammed the patient’s own fat-derived cells into insulin-producing pancreatic islet cells and transplanted them beneath the abdominal anterior rectus sheath. The patient achieved insulin independence within 75 days, maintained excellent blood glucose control for one year, and reduced HbA1c to non-diabetic levels without transplant-related complications. Although based on a single patient, the study highlights the promising potential of regenerative stem cell therapy for treating Type 1 Diabetes.

First Human Trial of stem cell-derived islet transplant offers new hope for Type 1 Diabetes Read More »

Berberine and Probiotics create a ‘Gut Lipid Sink’ to improve cholesterol profile & prevent CVD risk

A recent clinical study found that combining berberine (BBR) with probiotics significantly improved postprandial hyperlipidemia in newly diagnosed patients with Type 2 diabetes. After 12 weeks, the combination therapy reduced post-meal total cholesterol and LDL cholesterol more effectively than either treatment alone. Multi-omics analyses also revealed notable reductions in lipid metabolites, including free fatty acids and phospholipids. Bifidobacterium breve has been identified as a key contributor, with berberine enhancing bacterial genes involved in fatty acid metabolism. These findings highlight the potential of berberine-probiotic therapy to improve lipid management and reduce cardiovascular risk in T2D patients.

Berberine and Probiotics create a ‘Gut Lipid Sink’ to improve cholesterol profile & prevent CVD risk Read More »

Moringa oleifera offers a cost-effective solution for microplastic removal from drinking water

Recently, Moringa oleifera have been studied to reduce aged polyvinyl chloride microplastics (Aged-PVC MPs) from drinking water. Acting as a natural coagulant, Moringa oleifera seed saline extract (MOS-SE), achieved an impressive 98.5% microplastic removal efficiency, matching the performance of conventional alum-based treatment. When tested, in-line filtration was found to be as effective as direct filtration, eliminating the need for an additional flocculation step and reducing treatment complexity and costs. Additionally, MOS-SE effectively reduced aromatic organic matter, demonstrating its potential as a sustainable, eco-friendly, and cost-effective solution for modern drinking water treatment.

Moringa oleifera offers a cost-effective solution for microplastic removal from drinking water Read More »

NIR-II Nanoprobes are transforming cancer imaging and image-guided surgery

Near-Infrared II (NIR-II) imaging technology is transforming biomedical imaging and disease diagnosis through the use of advanced probes such as quantum dots, lanthanide nanoparticles, carbon nanotubes, and organic dyes. Operating within the 1000–1700 nm wavelength range, NIR-II imaging offers deeper tissue penetration, higher spatial resolution, reduced autofluorescence, and superior signal-to-noise ratios compared with conventional NIR-I imaging (700–900 nm). These advantages have enabled significant progress in cancer detection, image-guided surgery, stem cell tracking, inflammation imaging, targeted drug delivery, and tumor vascular monitoring, resulting in enhanced diagnostic accuracy, improved therapeutic precision, and greater potential for personalized medicine.

NIR-II Nanoprobes are transforming cancer imaging and image-guided surgery Read More »